Episode Transcript
Available transcripts are automatically generated. Complete accuracy is not guaranteed.
SPEAKER_00 (00:07):
Ladies and
gentlemen, welcome back to part
two.
I'm with Eugene Manuele Junior.
He's a doctor, and as he wassaying before in the previous
episode, he was talking abouthis journey in the last five or
six years of coming out from acareer change into
entrepreneurship, starting anon-profit, which can, as we all
(00:28):
know, in the entrepreneurialworld, slightly challenging.
For those people who areentrepreneurs, we know about the
roller coaster, and we also arevery much aware of the trials,
tribulations, and challenges,not just in the business, but on
our personal lives.
It takes as a toll on all of usbecause we are no longer
(00:50):
adapting into a regime or asection of the world that makes
sense for a lot of other people,i.e., the 925 or shift work.
It can be scary.
Eugene, you talked earlier aboutthe challenges and overcoming
them.
What are the celebrations you'vehad?
SPEAKER_01 (01:13):
This is great
because often we don't celebrate
our wins enough.
We get so barred down in thework and a do and a do.
It's like we don't get tocelebrate, but I can happily say
we just hit the two-yearthreshold last month.
We have our trademark, ourwordmark trademark, and we are
waiting for our logo trademark,which should come up and be
(01:33):
approved soon.
We raised almost 200k in twoyears, less than two years.
We have been named best stem andcancel equity nonprofit in the
USA by AcquisitionInternational.
We were profiled onentrepreneur.com and we were
profiling in the Village Voiceabout the work that I've been
(01:55):
doing to really increaseworkforce diversity and how my
lived experience has driven whatI've created.
And we have the website, whichis now up and functional, and we
now have infographics on therethat are helping break down this
terminology for patients.
So that those are some bigblends.
And our other major thing is ourlung cancer summit, which is
(02:18):
approaching our third year, andwe really focus on not just the
problems that diverse andunderserved communities face
navigating lung cancer, but wefocus on different solutions
that stakeholders have createdat all levels that are actually
reducing disparities, reducinginequities, and improving
outcomes.
And that is like something I'mtruly proud of.
SPEAKER_00 (02:40):
I love that.
And it's it's amazing thatyou've got the bullet point
version of this is what I needto celebrate and remind myself
of.
Because a lot of people who wereinto the entrepreneurship
non-profit zone are going, Oh mygod, I haven't done anything.
And then that they fail to lookback or they don't remind
(03:01):
themselves to look back and go,Where have I been?
Where I've wherever you comefrom.
And this is such an importanttopic, I think, for a lot of
people out there who are boggeddown in this cycle of oh my god,
I'm not achieving anything.
Did you wake up?
Because there's a lot of thingsthat you can celebrate
incrementally in very small,very small packages.
(03:24):
In five years' time, threeyears' time, where do you want
this business to go?
Where do you want the nonprofitto be?
SPEAKER_01 (03:31):
I really want it to
be a go-to resource.
That's sort of the idea.
I want it to be a go-to resourcefor diverse and underserved
groups and even patients ingeneral to come and find
information about diseases,particularly cancer, but even
longer term asthma, ADHD, butwe're really focusing on cancer.
(03:51):
So they know they have trustedinformation that's vetted.
We can direct you to otherresources that may directly help
you, or to people that willactually see you as the patient
you are, as opposed to dictatingwhat you must be and fit into a
box.
I think by that point, we'llalso be more robustly
established and be known for thestuff we're doing and helping
(04:13):
groups engage with underservedcommunities and making sure we
have representation and researchand trials, even though that is
a challenging environment rightnow, but these things still need
to happen because we can't justkeep putting out products
developed on one race ethnicityand then get to post-market
analysis and wonder why theseother groups are having adverse
(04:34):
events.
Well, you have to think aboutthis as you design the stuff so
that you don't perpetuate thedisparities and inequities.
SPEAKER_00 (04:42):
I love that.
The other thing you mentionedearlier about overcoming sort of
your dynamics because you haveto become a different person,
slightly different person, or adifferent way of thinking, an
identity with doing this.
And you chose cancer.
Can you dive a bit deeper, ifyou will, into the why you chose
the cancer to focus on it?
(05:03):
Is interesting.
SPEAKER_01 (05:04):
I grew up, my father
was a chronic smoker, but he
never had lung cancer, but hehad emphysema.
And then, but I grew up as achronic asthmatic, and I was in
the hospital probably 20 to 30times a year until I was 10,
just with my asthma.
And associated with that asthmawas those anaphylactic allergies
that I still have, which reallymade growing up a challenge.
(05:27):
And I think one of my earlierscience for projects was just on
amount of tarin, nicotine, andcigarettes.
Like I didn't know I was goingto be a scientist.
We had to use these orderingbooks.
We didn't even, because wedidn't have everything when I
grew up.
So we need to be resourceful tobuy these testing kits and
stuff.
It just sort of, I got all thisstuff from the American Lung
Association that had pictures ofthroat cancer, tongue cancer,
(05:50):
all the stuff from chewingtobacco.
And so even though I knewsmoking was a risk factor for
lung cancer, and it still is, Inever somehow was in the frame
set that just because someonehas history of smoking, they
deserve to get lung cancer.
And unfortunately, with all theanti-smoking campaigns in the
80s and 90s, a lot of people nowassume that those that get lung
(06:12):
cancer only have history ofsmoking and they deserve to get
it, which is the worst thing youcan say to a patient.
Because there are now groupsthat have no smoking history or
have radon exposure, indoorcooking modules, exhaust, forest
fires.
These are all risk factors, butthey aren't typically associated
with smoking.
But these are other riskfactors.
(06:34):
So I really hate that we judgepeople that have lung cancer and
assume that they deserve to getit, which they don't.
That sort of started my path onthe science train, but I never
knew I was going to end up in acancer bill.
And then in high school, I gotmy very first research job at
the Michigan Cancer Foundation.
And this was thanks to myscience department head who
(06:55):
realized I had an aptitude forscience.
Now, like I said, because I'm afirst gen, I didn't know any of
these programs existed, but shetold me about the summer
research apprentice program Ishould apply for.
And I think that was 11th grade.
I got in, and then I realized,oh, there's a career doing
science.
And then I was hooked on scienceafter that.
And then it's sort of the cancerwork I didn't get as much of.
(07:15):
And then my undergrad was inmechanical engineering.
And so, and I'm from Michigan,and everything in mechanical was
carved, and that drove me crazy.
I was like, When the dyes, I'mlike, I'm so tired of looking at
axles and chassis, like, shootme.
So I'm rebelling and doing mysummaries, doing biomedical
research.
Let me get back to some realbiomedical engineering.
So that's how I got intobiomechanics and my master's.
(07:38):
And when my PhD came along andsaid, okay, let's get some real
cancer work back in.
And I just happened to do somerotations in one of the labs,
did a lot of work with drugmetabolism, cancer therapeutics.
And so that's ended up being thelab I joined.
So that was where I startedreally doing lung cancer.
It was never the idea that I wasgoing to do lung cancer, it just
(07:58):
happened that way.
And when I start in early 2000s,it was we had just maybe
discovered the first biomarker.
I think that was maybe 2003.
But I wasn't even in that area,but I was studying other drug
resistance enzymes.
But I will say, since that time,they lung cancer has driven a
(08:19):
lot of precision medicine andcancer across the board.
I think now we're up to maybe 11different biomarkers that can be
used for patients.
So you screen for cancer, thenyou can sort of look at the
molecular signature of thetumors, and this helps determine
what treatments they canreceive.
So we made a lot of advances,and unfortunately, not
everybody's benefiting fromthem.
(08:41):
Did I answer your question?
SPEAKER_00 (08:42):
I just realized I
want other no, no, it's all
good.
I I'm I'm just imagining now theChicagoans going, oh my god, he
said he said the thing theyshouldn't ever say about the
chassis.
And I just love that.
Downtown Chicago, no, theydidn't say that.
He did say that.
(09:04):
Love it.
When you're looking for uhsponsors, people who give the
funding side of things,investors.
What's the criteria that you'relooking for?
If someone's listening to thisnow going, that and I could help
them, what's the sort of thingthat you're looking for, and how
can they really help you?
SPEAKER_01 (09:22):
Well, really, the
biggest thing we need is
funding, sponsorships for theour lung cancer summit, support
for the different programs.
Besides our big lung cancerhealth equity summit or
intervention summit that will beOctober 24th and 25th.
We run our, we do the we createthe infographics for increasing
health literacy.
(09:43):
We started recording a podcastcalled Microscopes to Moonshots,
Real Stories in STEM, which isactually pretty exciting.
I get to talk to differentpeople in STEM fields about what
they've done, where they comefrom, how they got in the field,
and sort of it's really designedto help keep more so even
diverse and other circuits hearabout these fields at early ages
(10:06):
so they know that they're outthere because often you don't
know any of this until you getto college.
So, how can we circumvent andget this exposure out early?
So that that series really,really I'm happy that we finally
started recording.
And then in the last severalmonths, started two lung cancer
webinars about educatingpatients, researchers, etc.,
about different advances in lungcancer that impact patients or
(10:28):
solutions to different problems.
And this year we're focusing onrisk factors other than lung
cancer.
So those are the big thingswe're doing.
But the biggest thing is thesummit and then infographics.
So anyone interested in reallysupporting those initiatives,
anyone wanting to speak, anyonewanting to volunteer, because we
can use definitely volunteersbecause you know we're still
(10:48):
technically a party of one, soI'm wearing many hats, which is
what often founders, CEOs do,but there's only so many hours
of the day, so you have toliterally prioritize what I can
do today and what just will haveto wait, which is the hardest
thing to learn.
SPEAKER_00 (11:04):
I love that.
So the the summit I want tofocus on at the moment, where
can people find it?
What where can they sign up andthe dates?
SPEAKER_01 (11:13):
So the dates of the
summit are October 24th through
25th.
It is at the University ofIllinois Cancer Center, which is
a federally qualified healthcenter in right adjacent to
downtown of Chicago.
I love the work that they dowith that university.
They have some of the greatestdiversity in clinical trials and
lung cancer.
They do a great job with theirblack and Hispanic patients.
(11:35):
They really meet them where theyare.
And if people can't makeappointments, they check to see
if why they missed anappointment, if they can come in
on another time.
And they do such a great, greatjob.
And you can find moreinformation about it on our
website, check.org, SCHU.org.
If you go under events, you willsee third lung cancer solution
(11:55):
summit when we have the agendaprospectus and registration
pages.
We make sure that the summit isfree for patients, caregivers,
and survivors.
So it's free for those toattend, and then the price
scales up for you know nonprofitindustry, pharma, researchers.
So all the information is there.
Awesome.
SPEAKER_00 (12:15):
And where people can
find you, where do they get hold
of you?
Where's the we're on LinkedIn?
But is there any anything thatthey you want people to know?
SPEAKER_01 (12:22):
Yes, you can follow
me on LinkedIn.
I my posting goes in phases ofwhen I'm actually sitting at the
computer.
So there are sometimes when I'mreally something I disappear for
two weeks, then I come back.
But I can be followed onLinkedIn.
The org is also on LinkedIn,Instagram, and Facebook.
If you just do slashS-T-E-M-M-C-H-E-Q, you'll find
(12:47):
the org pages.
Um, we also have a blue skypage, which I do not, I'm
working on using more, but inthe grand scheme of social
media, that's the one that sortof lags behind the rest because
it's not directly connected tothe rest of my stuff, but it is
there.
So we do post some stuff there.
We are slowly working on gettinga YouTube page up, which will
(13:09):
have us soon we'll have ourseries on medical racism and
we'll have some of the webinarswe've recorded, but we're
working on that.
That's work in progress.
SPEAKER_00 (13:16):
Okay, awesome.
Eugene, thank you very much forjoining me today.
Is there any final message you'dlike to leave with the audience?
Uh hope, inspiration, or evenadvice?
Yeah, I will leave a couple.
SPEAKER_01 (13:27):
There's a one, just
don't be afraid to do something
because people tell you it won'twork.
You know, you have to believe inwhat you're gonna do, and the
worst thing you can do isthere's no problem with failure
if you have tried.
The bigger failure is if you'venever tried.
Because you always grow ifsomething doesn't work, but if
(13:49):
you don't try something, there'sno room for grate.
That's the biggest message, andI just say, and it's always try
to see people with respect andhow you want to be treated.
There's no I do not associatewith people that are what's the
word I want to use?
Well, use a nice word, jerks.
If someone is obnoxious, unruly,belligerent, like why would you
(14:09):
want to associate with them?
There's no reason to keep themin your sphere because they're
energy dreams.
So surround yourself with peoplethat understand and will support
you.
They don't have to be your bestbuddy, but you know, people that
are at least on a similar trackor understand what you're trying
to do.
So because you don't neednegative energy.
Those are the two big things.
SPEAKER_00 (14:27):
I love that advice.
Thank you very much for joiningme, Dr.
Eugene.
You're an awesome human being.
Keep up what you're doing, and Ihope you have an amazing event
and summit in Chicago inOctober.
To all my listeners, thank youvery much for joining me.
Thank you for being a part of myshow and sharing this message.
(14:47):
This is all about you and whatpeople like yourself bring to
the world.
This is Rice on the Ashes.
This is your story.
Remember, you are the miracle.
I'm Baz Porter.
Thanks for listening.
Talk to you soon.
Thank you.